Threats and Opportunities for European Pharmaceutical Wholesalers in a Changing Healthcare Environment PDF Download

Author: Andreas Cmolik
Publisher: Diplomica Verlag
ISBN: 3842871007
Category : Business & Economics
Languages : en
Pages : 91

View

Book Description
The aim of this book is to identify the major drivers of change within the European healthcare systems and to evaluate risks and opportunities confronting pharmaceutical full-line wholesalers. These businesses are the most important link between pharmaceutical manufacturing and the point of sale; providing one-stop-shopping for healthcare professionals across Europe. While on the one hand European governments are interested to ensure broad access to healthcare provision for the general public with a high level of quality, they are on the other hand concerned with limiting cost increases and with the need to cap healthcare spending. In addition, the pharmaceutical industry faces a strong need to cut costs by outsourcing non-core activities and establishing new routes to the customer, often bypassing the established supply chain. Changing healthcare environments across Europe ask for new strategies of pharmaceutical wholesalers to be fit for the future. This book deals with the advantages that can be derived from the changing landscape of healthcare provision. Aging populations, markets in transition, outsourcing activities of manufacturers and legal changes provide the potential to turn threats into opportunities and further develop the business model of pharmaceutical wholesaling. Even with profound structural changes in healthcare systems, pharmaceutical wholesalers are provided with significant potential to remain a vital part of the pharmaceutical supply chain and to prosper in the future.

Author: Andreas Cmolik
Publisher: diplom.de
ISBN: 3842818920
Category : Business & Economics
Languages : en
Pages : 88

View

Book Description
Inhaltsangabe:Introduction: Tradition and Change: Many of the well established Western European pharmaceutical wholesalers are companies with strong local traditions and roots dating back for several decades and more. GEHE Pharma Handel GmbH, one of the top pharmaceutical wholesalers in Germany, was celebrating its 175th birthday in 2010. AAH Pharmaceuticals Ltd., the UK s leading distributor of pharmaceutical and healthcare products, was established in 1923, and Herba Chemosan Apotheker-AG, Austria s largest pharmaceutical service and trading company, was established in 1916 as a cooperative from pharmacists for pharmacists. But having years to add does not equal getting old, as we will see in the course of this study. The times of transformation free eras have long gone, stability is not the norm anymore and the challenges being faced today are completely different. The globalisation of markets and competition has forced and still is forcing firms to make dramatic improvements not only to compete and prosper but also to merely survive . For many reasons, which will be detailed throughout this study, pharmaceutical wholesalers across Europe have been facing the need for improvements to secure sustainability and growth. In addition, there has been significant consolidation of pharmaceutical wholesalers in Europe affecting not only the distribution of market share but also the strategic orientation of the surviving firms . Healthcare in Transition: Not only within the European Union but also across the entire OECD countries, healthcare is one of the largest industries with a dominant position in terms of job creation and a dynamic force in terms of innovation. Despite significant achievements in the health status of populations, concerns prevail on how resources are used in healthcare and how to guarantee an efficient and effective use of modern medicine. The weight of healthcare expenses in relation to GDP has increased the demand to harmonise internationally different definitions and improve the cross-national comparability of data on healthcare expenses. Consequently, the OECD has developed the System of Health Accounts . This manual provides a common framework and supports the international comparison of healthcare data across countries and over time. A combination of medical progress, demographic changes and shifting social expectations are the major drivers of increasing health expenditures in developed countries. Within the EU-15, [...]

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

View

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309452961
Category : Medical
Languages : en
Pages : 583

View

Book Description
In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.

Author: Council of Europe
Publisher: Council of Europe
ISBN: 9789287144041
Category : Political Science
Languages : en
Pages : 228

View

Book Description
This publication contains the speeches and conclusions of a seminar held in October 1999, which looked at the role of the pharmacist as a co-guarantor of health security. The first theme was health challenges of the 21st Century, which included the safety of new therapies, the pharmacists role in risk management and the problems of the counterfeiting of drugs. The second theme concerned the challenges of the new technologies both the dangers of selling drugs over the internet and the opportunities of increased networking professional information. The final theme looked at the risks of the new technologies and the ways that the pharmacist could add value. The conclusions of the seminar will serve as the framework for a Resolution of the Council of Europe's Committee of Ministers.

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

View

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Author: Robin Guenther
Publisher: John Wiley & Sons
ISBN: 1118086821
Category : Architecture
Languages : en
Pages : 480

View

Book Description
"With this book, Robin Guenther and Gail Vittori show us how critical our green building mission is to the future of human health and secures a lasting legacy that will continue to challenge and focus the green building movement, the healthcare industry, and the world for years to come." —From the Foreword by Rick Fedrizzi, President, CEO and Founding Chair, U.S. Green Building Council INDISPENSABLE REFERENCE FOR THE FUTURE OF SUSTAINABLE HEALTHCARE DESIGN Written by a leading healthcare architect named one of Fast Company's 100 most creative people in business and a sustainability expert recognized by Time magazine as a Green Innovator, Sustainable Healthcare Architecture, Second Edition is fully updated to incorporate the latest sustainable design approaches and information as applied to hospitals and other healthcare facilities. It is the essential guide for architects, interior designers, engineers, healthcare professionals, and administrators who want to create healthy environments for healing. Special features of this edition include: 55 new project case studies, including comparisons of key sustainability indicators for general and specialty hospitals, sub-acute and ambulatory care facilities, and mixed-use buildings New and updated guest contributor essays spanning a range of health-focused sustainable design topics Evolving research on the value proposition for sustainable healthcare buildings Profiles of five leading healthcare systems and their unique sustainability journeys, including the UK National Health Service, Kaiser Permanente, Partners HealthCare, Providence Health & Services, and Gundersen Health System Focus on the intersection of healthcare, resilience, and a health promotion imperative in the face of extreme weather events Comparison of healthcare facility-focused green building rating systems from around the world Sustainable Healthcare Architecture, Second Edition is an indispensable resource for anyone interested in the design, construction, and operation of state-of-the-art sustainable healthcare facilities.

Author: Simona Vlad
Publisher: Springer Science & Business Media
ISBN: 3642042929
Category : Technology & Engineering
Languages : en
Pages : 441

View

Book Description
Projections for advances in medical and biological technology will transform medical care and treatment. This in great part is due to the result of the interaction and collaboration between medical sciences and engineering. These advances will result in substantial progress in health care and in the quality of life of the population. Frequently however, the implications of technologies in terms of increasing recurrent costs, additional required support services, change in medical practice and training needs are underestimated. As a result, the widespread irrational use of te- nologies leads to a wastage of scarce resources and weakens health systems performance. To avoid such problems, a syst- atic and effective Health Technology System must be developed and introduced, requiring the support and commitment of decision makers of all levels of the health system. The MediTech2009 conference aims to provide a special opportunity for the Romanian professionals involved in basic - search, R&D, industry and medical applications to exchange their know-how and build up collaboration in one of the most human field of science and techniques. The conference is intended to be an international forum for researchers and practit- ners interested in the advance in, and applications of biomedical engineering to exchange the latest research results and ideas in the areas covered by the topics (and not only!). We believe the reader will find the proceedings an impressive document of progress to date in this rapidly changing field.

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 030904491X
Category : Medical
Languages : en
Pages : 225

View

Book Description
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309133181
Category : Medical
Languages : en
Pages : 536

View

Book Description
The anthrax incidents following the 9/11 terrorist attacks put the spotlight on the nation's public health agencies, placing it under an unprecedented scrutiny that added new dimensions to the complex issues considered in this report. The Future of the Public's Health in the 21st Century reaffirms the vision of Healthy People 2010, and outlines a systems approach to assuring the nation's health in practice, research, and policy. This approach focuses on joining the unique resources and perspectives of diverse sectors and entities and challenges these groups to work in a concerted, strategic way to promote and protect the public's health. Focusing on diverse partnerships as the framework for public health, the book discusses: The need for a shift from an individual to a population-based approach in practice, research, policy, and community engagement. The status of the governmental public health infrastructure and what needs to be improved, including its interface with the health care delivery system. The roles nongovernment actors, such as academia, business, local communities and the media can play in creating a healthy nation. Providing an accessible analysis, this book will be important to public health policy-makers and practitioners, business and community leaders, health advocates, educators and journalists.